These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
555 related articles for article (PubMed ID: 12098849)
1. Influence of hydroxypropyl methylcellulose mixture, apparent viscosity, and tablet hardness on drug release using a 2(3) full factorial design. Khanvilkar KH; Huang Y; Moore AD Drug Dev Ind Pharm; 2002 May; 28(5):601-8. PubMed ID: 12098849 [TBL] [Abstract][Full Text] [Related]
2. Effects of manufacturing process variables on in vitro dissolution characteristics of extended-release tablets formulated with hydroxypropyl methylcellulose. Huang Y; Khanvilkar KH; Moore AD; Hilliard-Lott M Drug Dev Ind Pharm; 2003 Jan; 29(1):79-88. PubMed ID: 12602495 [TBL] [Abstract][Full Text] [Related]
3. In vitro release of ketoprofen from hydrophilic matrix tablets containing cellulose polymer mixtures. Vueba ML; Batista de Carvalho LA; Veiga F; Sousa JJ; Pina ME Drug Dev Ind Pharm; 2013 Nov; 39(11):1651-62. PubMed ID: 23094867 [TBL] [Abstract][Full Text] [Related]
4. [The factors influencing metoprolol succinate release from hydroxypropyl methylcellulose matrix tablet]. Huang G; Wang R; Wang D; Zhang Z; Deng S Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Jun; 23(3):587-91. PubMed ID: 16856395 [TBL] [Abstract][Full Text] [Related]
5. Drug release-modulating mechanism of hydrophilic hydroxypropylmethylcellulose matrix tablets: distribution of atoms and carrier and texture analysis. Park JB; Lim J; Kang CY; Lee BJ Curr Drug Deliv; 2013 Dec; 10(6):732-41. PubMed ID: 23855499 [TBL] [Abstract][Full Text] [Related]
6. Release Kinetics of Hydroxypropyl Methylcellulose Governing Drug Release and Hydrodynamic Changes of Matrix Tablet. Park C; Lee JH; Jin G; Ngo HV; Park JB; Tran TTD; Tran PHL; Lee BJ Curr Drug Deliv; 2022; 19(5):520-533. PubMed ID: 34420504 [TBL] [Abstract][Full Text] [Related]
7. Hydroxypropyl methylcellulose based cephalexin extended release tablets: influence of tablet formulation, hardness and storage on in vitro release kinetics. Saravanan M; Sri Nataraj K; Ganesh KS Chem Pharm Bull (Tokyo); 2003 Aug; 51(8):978-83. PubMed ID: 12913240 [TBL] [Abstract][Full Text] [Related]
8. Comparative study of propranolol hydrochloride release from matrix tablets with KollidonSR or hydroxy propyl methyl cellulose. Sahoo J; Murthy PN; Biswal S; Sahoo SK; Mahapatra AK AAPS PharmSciTech; 2008; 9(2):577-82. PubMed ID: 18459050 [TBL] [Abstract][Full Text] [Related]
9. Formulation and release characteristics of hydroxypropyl methylcellulose matrix tablet containing melatonin. Lee BJ; Ryu SG; Cui JH Drug Dev Ind Pharm; 1999 Apr; 25(4):493-501. PubMed ID: 10194604 [TBL] [Abstract][Full Text] [Related]
10. Oral controlled release formulations of rifampicin. Part II: Effect of formulation variables and process parameters on in vitro release. Hiremath PS; Saha RN Drug Deliv; 2008; 15(3):159-68. PubMed ID: 18379928 [TBL] [Abstract][Full Text] [Related]
11. In vitro controlled release of alfuzosin hydrochloride using HPMC-based matrix tablets and its comparison with marketed product. Nair A; Gupta R; Vasanti S Pharm Dev Technol; 2007; 12(6):621-5. PubMed ID: 18161635 [TBL] [Abstract][Full Text] [Related]
12. Swelling of hydroxypropyl methylcellulose matrix tablets. 2. Mechanistic study of the influence of formulation variables on matrix performance and drug release. Gao P; Skoug JW; Nixon PR; Ju TR; Stemm NL; Sung KC J Pharm Sci; 1996 Jul; 85(7):732-40. PubMed ID: 8818998 [TBL] [Abstract][Full Text] [Related]
13. Release characteristics and in vitro-in vivo correlation of pulsatile pattern for a pulsatile drug delivery system activated by membrane rupture via osmotic pressure and swelling. Lin HL; Lin SY; Lin YK; Ho HO; Lo YW; Sheu MT Eur J Pharm Biopharm; 2008 Sep; 70(1):289-301. PubMed ID: 18539015 [TBL] [Abstract][Full Text] [Related]
14. Interaction between fed gastric media (Ensure Plus®) and different hypromellose based caffeine controlled release tablets: comparison and mechanistic study of caffeine release in fed and fasted media versus water using the USP dissolution apparatus 3. Franek F; Holm P; Larsen F; Steffansen B Int J Pharm; 2014 Jan; 461(1-2):419-26. PubMed ID: 24342711 [TBL] [Abstract][Full Text] [Related]
15. Design and study of lamivudine oral controlled release tablets. Ravi PR; Ganga S; Saha RN AAPS PharmSciTech; 2007 Dec; 8(4):E101. PubMed ID: 18181522 [TBL] [Abstract][Full Text] [Related]
16. Mechanistic Approach to Understanding the Influence of USP Apparatus I and II on Dissolution Kinetics of Tablets with Different Operating Release Mechanisms. Lu Z; Fassihi R AAPS PharmSciTech; 2017 Feb; 18(2):462-472. PubMed ID: 27106916 [TBL] [Abstract][Full Text] [Related]
17. The influence of HPMC viscosity as FRC parameter on the release of low soluble drug from hydrophylic matrix tablets. Novak SD; Kuhelj V; Vrečer F; Baumgartner S Pharm Dev Technol; 2013; 18(2):343-7. PubMed ID: 21916601 [TBL] [Abstract][Full Text] [Related]
18. Design and in vitro evaluation of zidovudine oral controlled release tablets prepared using hydroxypropyl methylcellulose. Ravi PR; Ganga S; Saha RN Chem Pharm Bull (Tokyo); 2008 Apr; 56(4):518-24. PubMed ID: 18379101 [TBL] [Abstract][Full Text] [Related]
19. The consequence of the chemical composition of HPMC in matrix tablets on the release behaviour of model drug substances having different solubility. Viridén A; Wittgren B; Larsson A Eur J Pharm Biopharm; 2011 Jan; 77(1):99-110. PubMed ID: 21081160 [TBL] [Abstract][Full Text] [Related]
20. Formulation and evaluation of diclofenac controlled release matrix tablets made of HPMC and Poloxamer 188 polymer: An assessment on mechanism of drug release. Al-Hanbali OA; Hamed R; Arafat M; Bakkour Y; Al-Matubsi H; Mansour R; Al-Bataineh Y; Aldhoun M; Sarfraz M; Dardas AKY Pak J Pharm Sci; 2018 Jan; 31(1(Suppl.)):345-351. PubMed ID: 29386164 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]